{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T02:01:48Z","timestamp":1772244108612,"version":"3.50.1"},"reference-count":38,"publisher":"Deutscher Arzte-Verlag GmbH","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.3238\/arztebl.2015.0683","type":"journal-article","created":{"date-parts":[[2018,5,2]],"date-time":"2018-05-02T05:24:09Z","timestamp":1525238649000},"source":"Crossref","is-referenced-by-count":14,"title":["Trans-Sector Integrated Treatment in Psychosis and Addiction"],"prefix":"10.3238","author":[{"given":"Euphrosyne","family":"Gouzoulis-Mayfrank","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanne","family":"K\u00f6nig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Koebke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Schnell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Schmitz-Buhl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f6rg","family":"Daumann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"11437","published-online":{"date-parts":[[2015,10,9]]},"reference":[{"key":"10.3238\/arztebl.2015.0683_ref1","doi-asserted-by":"crossref","unstructured":"Regier DA, Farmer ME, Rae DS, et al.: Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA 1990; 264: 2511\u20138","DOI":"10.1001\/jama.264.19.2511"},{"key":"10.3238\/arztebl.2015.0683_ref2","doi-asserted-by":"crossref","unstructured":"Drake RE, Mueser KT: Psychosocial approaches to dual diagnosis. Schizophr Bull 2000; 26:105\u201318","DOI":"10.1093\/oxfordjournals.schbul.a033429"},{"key":"10.3238\/arztebl.2015.0683_ref3","doi-asserted-by":"crossref","unstructured":"Gouzoulis-Mayfrank E: Komorbidit\u00e4t Psychose und Sucht \u2013 Grundlagen und Praxis. Mit Manualen f\u00fcr die Psychoedukation und Verhaltenstherapie. 2. erweiterte Auflage unter Mitarbeit von Schnell T. Darmstadt: Steinkopff 2007.","DOI":"10.1007\/3-540-30100-3_28"},{"key":"10.3238\/arztebl.2015.0683_ref4","doi-asserted-by":"crossref","unstructured":"Dixon L: Dual diagnosis of substance abuse in schizophrenia: prevalence and impact on outcomes. Schizophr Res 1999; 35 Suppl: 93\u2013100","DOI":"10.1016\/S0920-9964(98)00161-3"},{"key":"10.3238\/arztebl.2015.0683_ref5","doi-asserted-by":"crossref","unstructured":"Mueser KT, Yarnold PR, Rosenberg SD, Swett C Jr, Miles KM, Hill D: Substance use disorder in hospitalized severely mentally ill psychiatric patients: prevalence, correlates, and subgroups. Schizophr Bull 2000; 26: 179\u201392","DOI":"10.1093\/oxfordjournals.schbul.a033438"},{"key":"10.3238\/arztebl.2015.0683_ref6","doi-asserted-by":"crossref","unstructured":"Schnell T: Klinische Prognose schizophrener Patienten mit Cannabisabh\u00e4ngigkeit. Nervenarzt 2014; 85: 1084\u201392","DOI":"10.1007\/s00115-013-3926-1"},{"key":"10.3238\/arztebl.2015.0683_ref7","doi-asserted-by":"crossref","unstructured":"Drake RE, Mercer-McFadden C, Mueser KT, McHugo GJ, Bond GR: Review of integrated mental health and substance abuse treatment for patients with dual disorders. Schizophr Bull 1998; 24: 589\u2013608","DOI":"10.1093\/oxfordjournals.schbul.a033351"},{"key":"10.3238\/arztebl.2015.0683_ref8","doi-asserted-by":"crossref","unstructured":"Drake RE, Mueser KT, Brunette MF, McHugo GJ: A review of treatments for people with severe mental illnesses and co-occurring substance use disorders. Psychiatr Rehabil J 2004; 27: 360\u201374","DOI":"10.2975\/27.2004.360.374"},{"key":"10.3238\/arztebl.2015.0683_ref9","doi-asserted-by":"crossref","unstructured":"Drake RE, O\u2019Neal EL, Wallach MA: A systematic review of psychosocial research on psychosocial interventions for people with co-occurring severe mental and substance use disorders. J Subst Abuse Treatment 2008; 34: 123\u201338","DOI":"10.1016\/j.jsat.2007.01.011"},{"key":"10.3238\/arztebl.2015.0683_ref10","unstructured":"DGPPN (Hrsg.): S3-Praxisleitlinien in Psychiatrie und Psychotherapie. Band 1 \u2013 Behandlungsleitlinie Schizophrenie. Darmstadt: Steinkopff-Verlag 2006; 225\u2013227."},{"key":"10.3238\/arztebl.2015.0683_ref11","doi-asserted-by":"crossref","unstructured":"Cleary M, Hunt GE, Matheson SL, Siegfried N, Walter G: Psychosocial interventions for people with both severe mental illness and substance misuse. Cochrane Database Syst Rev 2008; 23: CD001088","DOI":"10.1002\/14651858.CD001088.pub2"},{"key":"10.3238\/arztebl.2015.0683_ref12","doi-asserted-by":"crossref","unstructured":"Barrowclough C, Haddock G, Wykes T, et al.: Integrated motivational interviewing and cognitive behavioural therapy for people with psychosis and comorbid substance misuse: randomised controlled trial. BMJ 2010; 341: c6325","DOI":"10.1136\/bmj.c6325"},{"key":"10.3238\/arztebl.2015.0683_ref13","doi-asserted-by":"crossref","unstructured":"Hjorthoj CR, Fohlmann A, Larsen AM, Gluud C, Arendt M, Nordentoft M: Specialized psychosocial treatment plus treatment as usual (TAU) versus TAU for patients with cannabis use disorder and psychosis: the CapOpus randomized trial. Psychol Med 2013; 43: 1499\u2013510","DOI":"10.1017\/S0033291712002255"},{"key":"10.3238\/arztebl.2015.0683_ref14","doi-asserted-by":"crossref","unstructured":"Hunt GE, Siegfried N, Morley K, Sitharthan T, Cleary M: Psychosocial interventions for people with both severe mental illness and substance misuse. Cochrane Database Syst Rev 2013; 10: CD001088","DOI":"10.1002\/14651858.CD001088.pub3"},{"key":"10.3238\/arztebl.2015.0683_ref15","doi-asserted-by":"crossref","unstructured":"McLoughlin BC, Pushpa-Rajah JA, Gillies D, et al.: Cannabis and schizophrenia. Cochrane Database Syst Rev 2014; 10: CD004837","DOI":"10.1002\/14651858.CD004837.pub3"},{"key":"10.3238\/arztebl.2015.0683_ref16","unstructured":"National Institute for Health and Care Excellence (NICE): Psychosis with coexisting substance misuse: assessment and management in adults and young people, Clinical Guideline 120. London: NICE 2011."},{"key":"10.3238\/arztebl.2015.0683_ref17","doi-asserted-by":"crossref","unstructured":"Bechdolf A, Pohlmann B, G\u00fcttgemanns J, et al.: Stadienabh\u00e4ngige Motivationsbehandlung bei Patienten mit der Doppeldiagnose Psychose und Sucht: Ergebnisse einer randomisierten Studie. Nervenarzt 2012; 83: 888\u201396","DOI":"10.1007\/s00115-011-3331-6"},{"key":"10.3238\/arztebl.2015.0683_ref18","doi-asserted-by":"crossref","unstructured":"Gouzoulis-Mayfrank E: KompAkt: Komorbidit\u00e4t Psychose und Abh\u00e4ngigkeit \u2013 Psychoedukatives Training. In: Gouzoulis-Mayfrank E (ed.): Komorbidit\u00e4t Psychose und Sucht \u2013 Grundlagen und Praxis. Mit Manualen f\u00fcr die Psychoedukation und Verhaltenstherapie. 2. erweiterte Auflage unter Mitarbeit von Schnell T. Darmstadt: Steinkopff 2007; 75\u2013103.","DOI":"10.1007\/3-540-30100-3_28"},{"key":"10.3238\/arztebl.2015.0683_ref19","doi-asserted-by":"crossref","unstructured":"Schnell T, Gouzoulis-Mayfrank E: KomPASs: Komorbidit\u00e4t Psychose und Abh\u00e4ngigkeit \u2013 Skills Training. In: Gouzoulis-Mayfrank E (ed.): Komorbidit\u00e4t Psychose und Sucht \u2013 Grundlagen und Praxis. Mit Manualen f\u00fcr die Psychoedukation und Verhaltenstherapie. 2. erweiterte Auflage unter Mitarbeit von Schnell T. Darmstadt: Steinkopff 2007; 105\u2013172","DOI":"10.1007\/978-3-7985-1769-1_7"},{"key":"10.3238\/arztebl.2015.0683_ref20","doi-asserted-by":"crossref","unstructured":"Baker AL, Thornton LK, Hides L, Dunlop A: Treatment of cannabis use among people with psychotic disorders: a critical review of randomised controlled trials. Curr Pharm Des 2012; 18: 4923\u201337","DOI":"10.2174\/138161212802884834"},{"key":"10.3238\/arztebl.2015.0683_ref21","doi-asserted-by":"crossref","unstructured":"Magura S, Laudet AB, Mahmood D, Rosenblum A, Knight E: Adherence to medication regimens and participation in dual-focus self-help groups. Psychiatr Serv 2002; 53: 310\u20136","DOI":"10.1176\/appi.ps.53.3.310"},{"key":"10.3238\/arztebl.2015.0683_ref22","doi-asserted-by":"crossref","unstructured":"Smeerdijk M, Keet R, Dekker N, et al.: Motivational interviewing and interaction skills training for parents to change cannabis use in young adults with recent-onset schizophrenia: a randomized controlled trial. Psychol Med 2012; 42: 1627\u201336","DOI":"10.1017\/S0033291711002832"},{"key":"10.3238\/arztebl.2015.0683_ref23","doi-asserted-by":"crossref","unstructured":"Mueser KT, Glynn SM, Cather C, et al.: A randomized controlled trial of family intervention for co-occurring substance use and severe psychiatric disorders. Schizophr Bull 2013; 39: 658\u201372","DOI":"10.1093\/schbul\/sbr203"},{"key":"10.3238\/arztebl.2015.0683_ref24","unstructured":"American Psychiatric Association (APA): Diagnostic and statistical manual of mental disorders: DSM IV-TR. 4th ed. Washington DC: American Psychiatric Press 2000."},{"key":"10.3238\/arztebl.2015.0683_ref25","unstructured":"Wittchen HU, Zaudig M, Fydrich T: SKID-I und SKID-II. Strukturiertes Klinisches Interview f\u00fcr DSM-IV. Achse I: Psychische St\u00f6rungen\/Achse II: Pers\u00f6nlichkeitsst\u00f6rungen. G\u00f6ttingen: Hogrefe 1997."},{"key":"10.3238\/arztebl.2015.0683_ref26","unstructured":"Wittchen HU, Zaudig M, Fydrich T: Handanweisung zu SKID-I und-II: Strukturiertes Klinisches Interview f\u00fcr DSM-IV (Achse I und II). G\u00f6ttingen: Hogrefe 1997."},{"key":"10.3238\/arztebl.2015.0683_ref27","doi-asserted-by":"crossref","unstructured":"McLellan AT, Luborsky L, Woody GE, et al.: An improved diagnostic evaluation instrument for substance abuse patients. The Addiction Severity Index. J Nerv Ment Dis 1980; 168: 26\u201333","DOI":"10.1097\/00005053-198001000-00006"},{"key":"10.3238\/arztebl.2015.0683_ref28","doi-asserted-by":"crossref","unstructured":"Gouzoulis-Mayfrank E, Daumann J, Tuchtenhagen F, et al.: Impaired cognitive performance in drug-free recreational ecstasy (MDMA) users. J Neurol Neurosurg Psychiatry 2000; 68: 719\u201325","DOI":"10.1136\/jnnp.68.6.719"},{"key":"10.3238\/arztebl.2015.0683_ref29","doi-asserted-by":"crossref","unstructured":"Gouzoulis-Mayfrank E, Thimm B, Rezk M, Hensen G, Daumann J: Memory impairment suggests hippocampal dysfunction in abstinent ecstasy (MDMA) users. Progress Neuro-Psychopharmacol Biol Psychiatry 2003; 27: 819\u201327","DOI":"10.1016\/S0278-5846(03)00114-3"},{"key":"10.3238\/arztebl.2015.0683_ref30","doi-asserted-by":"crossref","unstructured":"Gouzoulis-Mayfrank E, Fischermann T, Rezk M, Thimm B, Hensen G, Daumann J: Memory performance in polyvalent MDMA (ecstasy) users who continue or discontinue MDMA use. Drug Alcohol Depen 2005; 78: 317\u201323","DOI":"10.1016\/j.drugalcdep.2004.12.002"},{"key":"10.3238\/arztebl.2015.0683_ref31","doi-asserted-by":"crossref","unstructured":"Miller WR, Tonigan JS: Assessing drinkers\u00b4 motivation for change: The stages of change readiness and treatment eagerness scale (SOCRATES). Psychol Addict Behav 1996; 10: 81\u20139","DOI":"10.1037\/0893-164X.10.2.81"},{"key":"10.3238\/arztebl.2015.0683_ref32","unstructured":"Schmidt J, Lamprecht F, Wittmann WW: Zufriedenheit mit der station\u00e4ren Versorgung. Entwicklung eines Fragebogens und erste Validit\u00e4tsuntersuchungen. Psychother Psychosom Med Psychol 1989; 39: 248\u201355"},{"key":"10.3238\/arztebl.2015.0683_ref33","doi-asserted-by":"crossref","unstructured":"Endicott J, Spitzer RL, Fliess JL, et al.: The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance. Arch Gen Psychiat 1976; 33: 766\u201371","DOI":"10.1001\/archpsyc.1976.01770060086012"},{"key":"10.3238\/arztebl.2015.0683_ref34","doi-asserted-by":"crossref","unstructured":"Kay SR, Fiszbein A, Lindenmayer JP, et al.: Positive and negative syndromes in schizophrenia as a function of chronicity. Acta Psychiat Scand 1986; 74: 507\u201318","DOI":"10.1111\/j.1600-0447.1986.tb06276.x"},{"key":"10.3238\/arztebl.2015.0683_ref35","unstructured":"Schmidtke A, Fleckenstein P, Moises W, Beckmann H: Untersuchungen zur Reliabilit\u00e4t und Validit\u00e4t einer deutschen Version der Montgomery-Asberg Depression Rating Scale (MADRS). Schweiz Arch Neurol Psychiatr 1988; 139: 51\u201365."},{"key":"10.3238\/arztebl.2015.0683_ref36","unstructured":"Fahrenberg J, Myrtek M, Schumacher J, Br\u00e4hler E: Fragebogen zur Lebenszufriedenheit (FLZ). Handanweisung. G\u00f6ttingen: Hogrefe 2000."},{"key":"10.3238\/arztebl.2015.0683_ref37","doi-asserted-by":"crossref","unstructured":"Buchkremer G, Klingberg S, Holle R, et al.: Psychoeducational psychotherapy for schizophrenic patients and their key relatives or care-givers: results of a 2-year follow-up. Acta Psychiat Scand 1997; 96: 483\u201391","DOI":"10.1111\/j.1600-0447.1997.tb09951.x"},{"key":"10.3238\/arztebl.2015.0683_ref38","doi-asserted-by":"crossref","unstructured":"Schmidt LG, Gastpar M, Falkai P, Gaebel W (eds.): Evidenzbasierte Suchtmedizin \u2013 Behandlungsleitlinie Substanzbezogene St\u00f6rungen. K\u00f6ln: Deutscher \u00c4rzte-Verlag 2006.","DOI":"10.1024\/2006.05.17"}],"container-title":["Deutsches \u00c4rzteblatt international"],"original-title":[],"link":[{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.2015.0683","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,6]],"date-time":"2021-12-06T09:03:50Z","timestamp":1638781430000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.2015.0683"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,9]]},"references-count":38,"URL":"https:\/\/doi.org\/10.3238\/arztebl.2015.0683","relation":{"is-cited-by":[{"id-type":"doi","id":"10.1007\/978-3-642-55125-3_72","asserted-by":"object"}]},"ISSN":["1866-0452"],"issn-type":[{"value":"1866-0452","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,9]]}}}